{"id":"https://openalex.org/W1911110901","doi":"https://doi.org/10.1056/nejm200307243490417","title":"Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism","display_name":"Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism","publication_year":2003,"publication_date":"2003-07-23","ids":{"openalex":"https://openalex.org/W1911110901","doi":"https://doi.org/10.1056/nejm200307243490417","mag":"1911110901","pmid":"https://pubmed.ncbi.nlm.nih.gov/12878749"},"language":"en","primary_location":{"id":"doi:10.1056/nejm200307243490417","doi":"https://doi.org/10.1056/nejm200307243490417","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejm200307243490417","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pure.uva.nl/ws/files/3458916/30958_141135y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086661348","display_name":"C.J.J. van Dongen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1326872476","display_name":"Maimonides Medical Center","ror":"https://ror.org/00g651r29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1326872476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlo J J van Dongen","raw_affiliation_strings":["Maimonides medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maimonides medical Center","institution_ids":["https://openalex.org/I1326872476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111455603","display_name":"Martin H. Prins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1326872476","display_name":"Maimonides Medical Center","ror":"https://ror.org/00g651r29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1326872476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin H Prins","raw_affiliation_strings":["Maimonides medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maimonides medical Center","institution_ids":["https://openalex.org/I1326872476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042290277","display_name":"Harry Roger Buller","orcid":"https://orcid.org/0000-0002-8374-0930","observed_orcids":["https://orcid.org/0000-0002-8374-0930","https://orcid.org/0009-0000-4547-0901"]},"institutions":[{"id":"https://openalex.org/I1326872476","display_name":"Maimonides Medical Center","ror":"https://ror.org/00g651r29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1326872476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry R B\u00fcller","raw_affiliation_strings":["Maimonides medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maimonides medical Center","institution_ids":["https://openalex.org/I1326872476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1326872476"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"349","issue":"4","first_page":"398","last_page":"400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/low-intensity-anticoagulation","display_name":"low-intensity anticoagulation","score":0.9200000166893005},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9629999995231628},{"id":"https://openalex.org/keywords/recurrent-thrombosis","display_name":"recurrent thrombosis","score":0.6679999828338623},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.8299999833106995},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9627289772033691},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.8512783050537109},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.8036611080169678},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4429016709327698},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35666173696517944},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.269040048122406},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.21704891324043274}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020246","descriptor_name":"Venous Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":10,"locations":[{"id":"doi:10.1056/nejm200307243490417","doi":"https://doi.org/10.1056/nejm200307243490417","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejm200307243490417","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:12878749","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12878749","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Comment"},{"id":"pmid:12879888","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12879888","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Comment"},{"id":"pmid:12879889","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12879889","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Comment"},{"id":"pmid:12879891","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12879891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Comment"},{"id":"pmid:12879892","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12879892","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Comment"},{"id":"pmh:oai:dare.uva.nl:openaire_cris_publications/fbd60a8f-92fb-4b02-87b0-edbd9d99b1f2","doi":null,"is_oa":true,"landing_page_url":"https://handle.uba.uva.nl/personal/pure/en/publications/lowintensity-warfarin-therapy-for-the-prevention-of-recurrent-venous-thromboembolism-letter(fbd60a8f-92fb-4b02-87b0-edbd9d99b1f2).html","pdf_url":"https://pure.uva.nl/ws/files/3458916/30958_141135y.pdf","source":{"id":"https://openalex.org/S4306400088","display_name":"UvA-DARE (University of Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887064364","host_organization_name":"University of Amsterdam","host_organization_lineage":["https://openalex.org/I887064364"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Dongen, C J J, Prins, M H & B\u00fcller, H R 2003, 'Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism (letter)', The New England journal of medicine, vol. 349, pp. 398-398.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/4baad2db-f7f4-464a-82a8-7eae0f8e2a65","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/lowintensity-warfarin-therapy-for-the-prevention-of-recurrent-venous-thromboembolism(4baad2db-f7f4-464a-82a8-7eae0f8e2a65).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"New England journal of medicine, 349(4). Massachussetts Medical Society","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/fbf811e4-d11a-4a70-be1b-bf2ce52217ec","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/fbf811e4-d11a-4a70-be1b-bf2ce52217ec","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Dongen, C J J, Prins, M H & B\u00fcller, H R 2003, 'Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism', New England journal of medicine, vol. 349, no. 4, pp. 398-400; author reply 398-400. https://doi.org/10.1056/NEJM200307243490417","raw_type":"info:eu-repo/semantics/annotation"},{"id":"pmh:uvapub:oai:dare.uva.nl:publications/fbd60a8f-92fb-4b02-87b0-edbd9d99b1f2","doi":null,"is_oa":true,"landing_page_url":"https://dare.uva.nl/personal/pure/en/publications/lowintensity-warfarin-therapy-for-the-prevention-of-recurrent-venous-thromboembolism-letter(fbd60a8f-92fb-4b02-87b0-edbd9d99b1f2).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The New England journal of medicine, 349, 398 - 398. Massachussetts Medical Society","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:dare.uva.nl:openaire_cris_publications/fbd60a8f-92fb-4b02-87b0-edbd9d99b1f2","doi":null,"is_oa":true,"landing_page_url":"https://handle.uba.uva.nl/personal/pure/en/publications/lowintensity-warfarin-therapy-for-the-prevention-of-recurrent-venous-thromboembolism-letter(fbd60a8f-92fb-4b02-87b0-edbd9d99b1f2).html","pdf_url":"https://pure.uva.nl/ws/files/3458916/30958_141135y.pdf","source":{"id":"https://openalex.org/S4306400088","display_name":"UvA-DARE (University of Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887064364","host_organization_name":"University of Amsterdam","host_organization_lineage":["https://openalex.org/I887064364"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Dongen, C J J, Prins, M H & B\u00fcller, H R 2003, 'Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism (letter)', The New England journal of medicine, vol. 349, pp. 398-398.","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1911110901.pdf","grobid_xml":"https://content.openalex.org/works/W1911110901.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W300012118","https://openalex.org/W2087646765","https://openalex.org/W2112757583","https://openalex.org/W2120247650","https://openalex.org/W2165410879","https://openalex.org/W2312530434","https://openalex.org/W2327974959","https://openalex.org/W2331935930","https://openalex.org/W2332640098","https://openalex.org/W2413633207"],"related_works":["https://openalex.org/W2429535407","https://openalex.org/W4244050570","https://openalex.org/W4236833181","https://openalex.org/W2400364894","https://openalex.org/W2435321799","https://openalex.org/W1583318284","https://openalex.org/W2418696462","https://openalex.org/W2777626213","https://openalex.org/W2400478384","https://openalex.org/W4247192879"],"abstract_inverted_index":{"Low-Intensity":[0],"Warfarin":[1],"Therapy":[2],"for":[3],"the":[4,10,18,46,89,96,104,118,125],"Prevention":[5],"of":[6,48,52,85,91,99,107,120],"Recurrent":[7],"Venous":[8],"Thromboembolismto":[9],"editor:":[11],"We":[12],"have":[13],"two":[14,97],"major":[15,121],"concerns":[16],"regarding":[17],"report":[19],"by":[20,114],"Ridker":[21],"et":[22],"al.":[23],"on":[24],"low-intensity":[25],"warfarin":[26,38,66,75,100,110,133,139],"therapy":[27,39,76,134],"(April":[28],"10":[29],"issue).":[30],"1":[31],"First,":[32],"in":[33,41,45,79,83,117],"this":[34],"study,":[35],"low-dose,":[36],"long-term":[37],"resulted":[40,78],"a":[42,80],"relative":[43,81],"reduction":[44,82],"risk":[47,84,90,119],"recurrent":[49],"venous":[50],"thromboembolism":[51],"64":[53],"percent":[54],"as":[55],"compared":[56],"with":[57,95],"placebo.However,":[58],"data":[59],"from":[60],"another":[61],"trial":[62],"show":[63],"that":[64,131],"full-dose":[65,74,109,132],"is":[67,93,111,130,135],"more":[68],"effective":[69],"than":[70],"low-dose":[71,138],"warfarin.2":[72],"Indeed,":[73],"has":[77],"90":[86],"percent.3In":[87],"addition,":[88],"bleeding":[92,122],"similar":[94],"intensities":[98],"treatment":[101],"(Table":[102],"1).Hence,":[103],"added":[105],"efficacy":[106],"conventional,":[108],"not":[112],"offset":[113],"an":[115],"increase":[116],"episodes,":[123],"and":[124],"only":[126],"possible":[127],"evidence-based":[128],"conclusion":[129],"preferable":[136],"to":[137],"therapy.":[140]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}